Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction

Patients with neurogenic lower urinary tract dysfunction (NLUTD) experience urinary incontinence with or without difficult urination, which might promote recurrent urinary tract infection (UTI) and exacerbate upper urinary tract function. Nonetheless, appropriate bladder management has been shown to...

Full description

Bibliographic Details
Main Authors:	Yuan-Hong Jiang, Sheng-Fu Chen, Hann-Chorng Kuo
Format:	Article
Language:	English
Published:	Korean Continence Society 2020-12-01
Series:	International Neurourology Journal
Subjects:	botulinum toxins urinary bladder, neurogenic detrusor urinary incontinence urodynamics
Online Access:	http://www.einj.org/upload/pdf/inj-2040354-177.pdf

Similar Items

Experience with different botulinum toxins for the treatment of refractory neurogenic detrusor overactivity
by: Cristiano M. Gomes, et al.
Published: (2010-02-01)

Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction
by: Hann-Chorng Kuo
Published: (2020-06-01)

Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis
by: Shang-Jun Wu, et al.
Published: (2019-01-01)

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
by: Qin-Qin Gong, et al.
Published: (2020-01-01)

The use of botulinum toxin for the treatment of overactive bladder syndrome
by: Bogdan Orasanu, et al.
Published: (2013-01-01)

Botulinum Toxin in Neurogenic Detrusor Overactivity
by: Carlos Arturo Levi D'Ancona, et al.
Published: (2012-09-01)

BOTULINUM IN MODERN UROLOGY
by: A. D. KAPRIN, et al.
Published: (2016-12-01)

Taiwanese Continence Society clinical guidelines for diagnosis and management of neurogenic lower urinary tract dysfunction
by: Hann-Chorng Kuo, et al.
Published: (2014-06-01)

Stroke and lower urinary tract symptoms: A neurosurgical view
by: Yu-Cheng Chou, et al.
Published: (2019-01-01)

Does botulinum therapy affect the urine microbiome of patients with neurogenic bladder? Metagenomic sequencing results
by: E. S. Philippova, et al.
Published: (2020-10-01)

The application of botulinum toxin in the treatment of overactive bladder
by: Justyna Wojcik, et al.
Published: (2020-09-01)

Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson Disease
by: Gregory Vurture, et al.
Published: (2019-09-01)

Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity
by: Sheng-Fu Chen, et al.
Published: (2015-07-01)

Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature
by: David C. Moore, et al.
Published: (2016-03-01)

Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
by: Giuseppe Lombardi, et al.

Early treatment improves urodynamic prognosis in neurogenic voiding dysfunction: 20 years of experience,
by: Lucia M. Costa Monteiro, et al.

Early treatment improves urodynamic prognosis in neurogenic voiding dysfunction: 20 years of experience
by: Lucia M. Costa Monteiro, et al.
Published: (2017-07-01)

Eight-Year Experience With Botulinum Toxin Type-A Injections for the Treatment of Nonneurogenic Overactive Bladder: Are Repeated Injections Worthwhile?
by: Shannon HK Kim, et al.
Published: (2016-03-01)

Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients
by: S. Deffontaines-Rufin, et al.
Published: (2011-10-01)

Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction
by: Eugenia Fragalà, et al.
Published: (2015-12-01)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

Botulinum Toxin Injection for Medically Refractory Neurogenic Bladder in Children: A Systematic Review
by: Shu-Yu Wu, et al.
Published: (2021-06-01)

Neurogenic Bladder in Lyme Disease
by: Mi-hwa Kim, et al.
Published: (2012-12-01)

DISORDERS OF URODYNAMICS OF LOWER URINARY TRACTS IN TUBERCULOSIS SPONDYLITIS PATIENTS
by: A. N. Muravev, et al.
Published: (2015-10-01)

Urodynamic characteristics of lower urinary tract of patients with idiopathic overactive bladder
by: Yuriy M Dekhtiar, et al.
Published: (2019-01-01)

Use of onabotulinum toxin A in patients with idiopathic overactive bladder and a lack of efficacy, intolerance or contraindication with anticholinergics
by: Irma Amparo Ospina-Galeano, et al.
Published: (2018-01-01)

Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now?
Published: (2023)

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
by: Chun-Hou Liao, et al.
Published: (2015-12-01)

Urinary Tract Infection in Children with Neurogenic Bladder Dysfunction
by: Yu.B. Bielan, et al.
Published: (2016-04-01)

Managing the urinary tract in spinal cord injury
by: Simon C.W Harrison
Published: (2010-01-01)

Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction
by: Jia-Fong Jhang, et al.
Published: (2018-06-01)

USE OF URODYNAMIC TEST IN MEN WITH LOWER URINARY TRACT SYMPTOMS: EVALUATION OF 150 PATIENTS
by: M KABIRI, et al.
Published: (2003-09-01)

The innovative therapeutic application of botulinum toxin type A in urology patients
by: Chrysoula Belai, et al.
Published: (2016-06-01)

Botulinum toxin A for the Treatment of Overactive Bladder
by: Po-Fan Hsieh, et al.
Published: (2016-02-01)

Optimal bladder diary duration for patients with suprapontine neurogenic lower urinary tract dysfunction
by: Charalampos Konstantinidis, et al.

A Comparative Observational Study to Evaluate the Efficacy of Mid-Urethral Sling with Botulinum Toxin A Injection in Urinary Incontinence Patients
by: Yi-Huei Chang, et al.
Published: (2020-06-01)

The Current Positioning of Augmentation Enterocystoplasty in the Treatment for Neurogenic Bladder
by: Seong Jin Jeong, et al.
Published: (2020-09-01)

In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections
by: Banakhar M, et al.
Published: (2021-09-01)

Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?
by: Sheng-Fu Chen, et al.
Published: (2021-01-01)

Typical Value Ranges and Typical Signal Patterns in the Initial Cough in Patients With Neurogenic Bladder: Quality Control in Urodynamic Studies
by: Tianji Lu, et al.
Published: (2016-09-01)